What dose of Wegovy will you need?

Quick answer

The dose of Wegovy depends on whether you use the weekly injection or daily tablet, how long you have been taking it and how well you tolerate it. A doctor sets gradual increases and reviews your response; the two formulations are not equivalent milligram for milligram and should not be substituted yourself.

What dose of Wegovy will you need?

Your Wegovy dose should be chosen and reviewed by your prescriber, with gradual increases to help tolerability. The right plan depends on the formulation, licensed indication, response and side effects. A higher dose is not automatically better, and you should not change doses or switch between injections and tablets yourself.

Why does injectable Wegovy start at a low dose?

Wegovy contains semaglutide, which acts like glucagon-like peptide-1 (GLP-1), a hormone involved in appetite and blood sugar regulation. Starting low helps your body adjust, particularly to nausea, vomiting and other digestive effects. Early treatment is not a test of willpower or a promise of a particular amount of weight loss.

The licensed weekly injection schedule begins at 0.25 mg and progresses through 0.5 mg, 1 mg and 1.7 mg to the usual maintenance dose of 2.4 mg. These steps normally last four weeks each. This describes the licence, not a personal prescription: significant symptoms may mean your clinician delays an increase or returns to a previous dose.

Is 2.4 mg still the highest licensed injection dose?

No. Current UK authorisation also permits 7.2 mg weekly for weight management in adults with obesity, with an initial body mass index (BMI, weight relative to height) of at least 30. A prescriber may consider it if needed after at least four weeks at 2.4 mg.

This higher-dose option is not for adolescents, adults whose initial BMI was below 30, or treatment solely to reduce serious cardiovascular events. It is not a routine next step for everyone. A single-dose 7.2 mg pen is authorised; the instructions differ from those for other devices. Follow the prescription and the leaflet for the exact product supplied rather than assembling a higher dose yourself.

Are Wegovy tablets now licensed in the UK?

Yes. The Medicines and Healthcare products Regulatory Agency approved daily oral Wegovy for adult weight management in June 2026. It has a separate dose-escalation regimen and specific empty-stomach instructions that affect absorption. Oral and injected milligram amounts are not interchangeable, and you must not combine them or convert the dose yourself. Authorisation does not guarantee availability or NHS access.

What should happen if you feel unwell or miss treatment?

Report persistent digestive symptoms rather than pushing through to a higher dose. Vomiting and diarrhoea can cause dehydration and affect kidney function. Severe, persistent abdominal pain, particularly extending to the back, needs urgent assessment for pancreatitis, meaning inflammation of the pancreas. Stop treatment if this is suspected. Sudden loss of vision also needs urgent medical attention.

For a missed injection, a longer interruption or switching formulation, ask your pharmacist or prescriber and follow the relevant leaflet. Do not double up or restart a previous high dose without advice.

Does reaching your goal mean stopping?

Not necessarily. Ongoing reviews consider weight maintenance, nutrition, side effects and your preferences. Appetite and weight can increase after stopping, and there is no universal taper that prevents this. NHS service limits are not the same as a biological deadline or a licence-wide maximum duration. Plan any change with your clinician.

Sources & further reading

Dr Chinnadorai Rajeswaran

Reviewed by

Dr Chinnadorai Rajeswaran

Specialist Endocrinologist · MBBS MRCP FRCP

Last Reviewed: November 2026

Read about complex severe obesity and related care.